DOR BioPharma, Inc. Maintains AMEX Listing

MIAMI--(BUSINESS WIRE)--Dec. 9, 2005--DOR BioPharma, Inc. (“DOR” or the “Company”) (AMEX: DOR) announced today that the Company received notice from the American Stock Exchange (“AMEX”) that after a hearing on December 2 with a Listing Qualifications Panel of the Amex Committee on Securities (“the Panel”), it has been granted an extension within which to regain compliance with the continued listing standards of the AMEX.